Retractable Technologies Inc
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allerg… Read more
Retractable Technologies Inc (RVP) - Net Assets
Latest net assets as of September 2025: $76.78 Million USD
Based on the latest financial reports, Retractable Technologies Inc (RVP) has net assets worth $76.78 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($146.43 Million) and total liabilities ($69.65 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $76.78 Million |
| % of Total Assets | 52.43% |
| Annual Growth Rate | 10.84% |
| 5-Year Change | 74.76% |
| 10-Year Change | 180.94% |
| Growth Volatility | 893.34 |
Retractable Technologies Inc - Net Assets Trend (2000–2024)
This chart illustrates how Retractable Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Retractable Technologies Inc (2000–2024)
The table below shows the annual net assets of Retractable Technologies Inc from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $87.17 Million | -12.20% |
| 2023-12-31 | $99.29 Million | -6.80% |
| 2022-12-31 | $106.54 Million | +7.43% |
| 2021-12-31 | $99.17 Million | +98.82% |
| 2020-12-31 | $49.88 Million | +74.76% |
| 2019-12-31 | $28.54 Million | +11.43% |
| 2018-12-31 | $25.61 Million | -5.74% |
| 2017-12-31 | $27.17 Million | -3.32% |
| 2016-12-31 | $28.11 Million | -9.41% |
| 2015-12-31 | $31.03 Million | +15.65% |
| 2014-12-31 | $26.83 Million | -7.17% |
| 2013-12-31 | $28.90 Million | -19.11% |
| 2012-12-31 | $35.73 Million | -7.56% |
| 2011-12-31 | $38.65 Million | -0.64% |
| 2010-12-31 | $38.90 Million | +8.30% |
| 2009-12-31 | $35.92 Million | -14.89% |
| 2008-12-31 | $42.21 Million | -18.46% |
| 2007-12-31 | $51.76 Million | -13.31% |
| 2006-12-31 | $59.71 Million | -5.57% |
| 2005-12-31 | $63.24 Million | -0.67% |
| 2004-12-31 | $63.66 Million | +320.65% |
| 2003-12-31 | $15.13 Million | +103.50% |
| 2002-12-31 | $7.44 Million | +4473.23% |
| 2001-12-31 | $162.62K | -97.79% |
| 2000-12-31 | $7.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Retractable Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5998084700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $26.67 Million | 30.59% |
| Other Components | $73.39 Million | 84.19% |
| Total Equity | $87.17 Million | 100.00% |
Retractable Technologies Inc Competitors by Market Cap
The table below lists competitors of Retractable Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Born Inc
PINK:BRRN
|
$8.56 Million |
|
Allovir Inc
NASDAQ:ALVR
|
$8.56 Million |
|
Unlimited Travel Group UTG AB (publ)
ST:UTG
|
$8.57 Million |
|
Alba Mineral Resources plc
PINK:ALBAF
|
$8.57 Million |
|
Eurotel SA
WAR:ETL
|
$8.56 Million |
|
Seoul Electronics & Telecom Co. Ltd
KQ:027040
|
$8.55 Million |
|
Electra Real Estate Ltd
TA:ELCRE
|
$8.55 Million |
|
Pikko Land Development Tbk
JK:RODA
|
$8.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Retractable Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 99,287,659 to 87,170,691, a change of -12,116,968 (-12.2%).
- Net loss of 11,886,524 reduced equity.
- Dividend payments of 230,445 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.89 Million | -13.64% |
| Dividends Paid | $230.44K | -0.26% |
| Other Changes | $1.00 | +0.0% |
| Total Change | $- | -12.20% |
Book Value vs Market Value Analysis
This analysis compares Retractable Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.24x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.84x to 0.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-12-31 | $0.38 | $0.70 | x |
| 2001-12-31 | $0.01 | $0.70 | x |
| 2002-12-31 | $0.37 | $0.70 | x |
| 2003-12-31 | $0.62 | $0.70 | x |
| 2004-12-31 | $2.50 | $0.70 | x |
| 2005-12-31 | $2.71 | $0.70 | x |
| 2006-12-31 | $2.53 | $0.70 | x |
| 2007-12-31 | $2.18 | $0.70 | x |
| 2008-12-31 | $1.77 | $0.70 | x |
| 2009-12-31 | $1.51 | $0.70 | x |
| 2010-12-31 | $1.48 | $0.70 | x |
| 2011-12-31 | $1.47 | $0.70 | x |
| 2012-12-31 | $1.36 | $0.70 | x |
| 2013-12-31 | $1.07 | $0.70 | x |
| 2014-12-31 | $0.98 | $0.70 | x |
| 2015-12-31 | $1.05 | $0.70 | x |
| 2016-12-31 | $0.96 | $0.70 | x |
| 2017-12-31 | $0.85 | $0.70 | x |
| 2018-12-31 | $0.78 | $0.70 | x |
| 2019-12-31 | $0.87 | $0.70 | x |
| 2020-12-31 | $1.50 | $0.70 | x |
| 2021-12-31 | $2.90 | $0.70 | x |
| 2022-12-31 | $3.23 | $0.70 | x |
| 2023-12-31 | $3.32 | $0.70 | x |
| 2024-12-31 | $2.91 | $0.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Retractable Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.64%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -35.97%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.84x
- Recent ROE (-13.64%) is above the historical average (-182.25%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -141.74% | -108.33% | 0.47x | 2.78x | $-11.18 Million |
| 2001 | -4436.84% | -44.69% | 0.87x | 114.01x | $-7.23 Million |
| 2002 | -91.78% | -33.60% | 1.13x | 2.43x | $-7.57 Million |
| 2003 | 49.21% | 39.04% | 0.81x | 1.56x | $5.94 Million |
| 2004 | 85.91% | 254.12% | 0.28x | 1.20x | $48.32 Million |
| 2005 | -1.96% | -5.11% | 0.33x | 1.17x | $-7.56 Million |
| 2006 | -6.48% | -15.28% | 0.36x | 1.19x | $-9.84 Million |
| 2007 | -13.42% | -26.43% | 0.41x | 1.24x | $-12.12 Million |
| 2008 | -22.85% | -34.57% | 0.48x | 1.39x | $-13.86 Million |
| 2009 | -26.23% | -24.17% | 0.72x | 1.50x | $-13.01 Million |
| 2010 | 6.17% | 6.63% | 0.68x | 1.37x | $-1.49 Million |
| 2011 | 3.67% | 4.42% | 0.66x | 1.26x | $-2.45 Million |
| 2012 | -11.57% | -12.28% | 0.71x | 1.33x | $-7.71 Million |
| 2013 | -21.50% | -20.18% | 0.63x | 1.70x | $-9.10 Million |
| 2014 | -8.78% | -6.82% | 0.76x | 1.69x | $-5.04 Million |
| 2015 | 13.90% | 14.60% | 0.69x | 1.37x | $1.21 Million |
| 2016 | -13.15% | -12.39% | 0.77x | 1.38x | $-6.51 Million |
| 2017 | -13.75% | -10.83% | 0.90x | 1.40x | $-6.45 Million |
| 2018 | -5.23% | -4.03% | 0.90x | 1.44x | $-3.90 Million |
| 2019 | 11.03% | 7.53% | 0.91x | 1.61x | $293.99K |
| 2020 | 48.56% | 29.59% | 0.78x | 2.10x | $19.24 Million |
| 2021 | 56.53% | 29.76% | 0.88x | 2.15x | $46.15 Million |
| 2022 | 4.77% | 5.36% | 0.45x | 1.98x | $-5.58 Million |
| 2023 | -7.06% | -16.08% | 0.24x | 1.81x | $-16.94 Million |
| 2024 | -13.64% | -35.97% | 0.21x | 1.84x | $-20.60 Million |
Industry Comparison
This section compares Retractable Technologies Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Retractable Technologies Inc (RVP) | $76.78 Million | -141.74% | 0.91x | $8.56 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |